Citation Impact
Citing Papers
Complement and microglia mediate early synapse loss in Alzheimer mouse models
2016 StandoutScience
Probing mucin-type O-linked glycosylation in living animals
2006 StandoutNobel
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
Complement Factor H Polymorphism and Age-Related Macular Degeneration
2005 StandoutScience
A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation
2003 StandoutNobel
Inducible costimulator is required for type 2 antibody isotype switching but not T helper cell type 2 responses in chronic nematode infection
2005 StandoutNobel
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
2004 StandoutScience
Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease.
1987
Impaired antipneumococcal antibody production in patients without spleens.
1985
Cochrane Database of Systematic Reviews
2003 Standout
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
2000
Immunization of pediatric solid‐organ transplantation candidates: Immunizations in transplant candidates
2005
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
RESPONSE TO DIPHTHERIA AND TETANUS BOOSTER VACCINATION IN PEDIATRIC RENAL TRANSPLANT RECIPIENTS1
1997
Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues
2013 Standout
Penicillin Resistance and Other Predictors of Mortality in Pneumococcal Bacteremia in a Population with High Human Immunodeficiency Virus Seroprevalence
1999
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates Causing Systematic Infections in Spain, 1979-1989
1990
Efficacy of Pneumococcal Vaccination in Adults
1994
Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice
2002
Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL
2003
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Immunogenicity of Haemophilus influenzae Type b Conjugate Vaccine in Allogeneic Bone Marrow Recipients
1992
Immunization with Haemophilus influenzae Type b Conjugate Vaccine in Children Given Bone Marrow Transplantation: Comparison with Healthy Age-Matched Controls
1998
Seven-Valent Pneumococcal Conjugate Vaccine in Pediatric Solid Organ Transplant Recipients
2009
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis
2005
Immune Recovery in Children With Malignancy After Cessation of Chemotherapy
1998
Immune Responses of Splenectomized Trauma Patients to the 23-Valent Pneumococcal Polysaccharide Vaccine at 1 versus 7 versus 14 Days after Splenectomy
1998
Bacterial Infection in Chronic Obstructive Pulmonary Disease
1992
Immunogenicity of Pneumococcal Vaccine in Heart Transplant Recipients
2001
Molecular characterization of a peripheral receptor for cannabinoids
1993 StandoutNature
Pneumococcal polysaccharide vaccine in children with chronic renal disease: A prospective study of antibody response and duration
1996
Pneumococcal Conjugate Vaccine Primes for Antibody Responses to Polysaccharide Pneumococcal Vaccine after Treatment of Hodgkin's Disease
1996
Pneumococcal Disease during HIV Infection
1992
A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease
1990
Clinical Efficacy of Pneumococcal Vaccine in the Elderly
1997
The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease
1999
Randomized Study of Early versus Late Immunization with Pneumococcal Conjugate Vaccine after Allogeneic Stem Cell Transplantation
2009
B Cells and Transplantation: An Educational Resource
2009
Response to Pneumococcal (PNCRM7) and Haemophilus Influenzae Conjugate Vaccines (HIB) in Pediatric and Adult Recipients of an Allogeneic Hematopoietic Cell Transplantation (alloHCT)
2008
The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
1991
Antibody blocks acquisition of bacterial colonization through agglutination
2014
Immune Response to Influenza Vaccine in Children With Inflammatory Bowel Disease
2009
Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
1998
Antibody Response to Diphtheria, Tetanus, and Poliomyelitis Vaccines in Relation to the Number of CD4+ T Lymphocytes in Adults Infected with Human Immunodeficiency Virus
1995
Immunogenicity of Pneumococcal Vaccine in Renal Transplant Recipients—Three Year Follow‐up of a Randomized Trial
2007
Pneumococcal Vaccine Response in Cirrhosis and Liver Transplantation
2000
EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
2011
Bacterial Pneumonia in Hospitalized Patients With HIV Infection
2000
Poor antibody response to pneumococcal polysaccharide vaccination suggests increased susceptibility to pneumococcal infection in splenectomized patients with hematological diseases
2005
Predictive Factors for Invasive Disease Due to Penicillin-Resistant Streptococcus pneumoniae: A Population-Based Study
1994
DIFFERENTIAL IMMUNE RESPONSE TO INFLUENZA AND PNEUMOCOCCAL VACCINATION IN IMMUNOSUPPRESSED PATIENTS AFTER HEART TRANSPLANTATION
1998
Immune dysfunction in patients with diabetes mellitus (DM)
1999
Community-Acquired Pneumonia in a Cohort of Former Injection Drug Users With and Without Human Immunodeficiency Virus Infection: Incidence, Etiologies, and Clinical Aspects
1996
23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial
2000
Immunogenicity and Safety of Pneumococcal Vaccination in Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus
2002
Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults
2002
Marginal zone macrophages and their role in the immune response against T‐independent type 2 antigens: modulation of the cells with specific antibody
1989
Vaccines for Transplant Recipients
2001
A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma
2004
Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults
2003
Antibody levels against Streptococcus pneumoniae and Haemophilus influenzae type b in a population of splenectomized individuals with varying vaccination status
1997
Power and Sample Size Calculations for Studies Involving Linear Regression
1998
Cancer immunotherapy comes of age
2011 StandoutNature
Preventing Bacterial Respiratory Tract Infections Among Persons Infected with Human Immunodeficiency Virus
1995
Antibody Titers and Immune Response to Diphtheria-Tetanus-Pertussis and Measles-Mumps-Rubella Vaccination in Children Treated for Acute Lymphoblastic Leukemia
2005
Should patients positive for HIV infection receive pneumococcal vaccine?
1995
Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
2009
Immunoglobulin G and Its Function in the Human Respiratory Tract
1988
Randomized, Double‐Blind, Controlled Trial of Pneumococcal Vaccination in Renal Transplant Recipients
2003
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Inefficacy of pneumococcal vaccine in a high-risk population
1987
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Cells in the Marginal Zone of the Spleen
1992
Synthesis, photochemistry, and biological activity of a caged photolabile acetylcholine receptor ligand
1989
A Randomized, Double-Blind Trial of Pneumococcal Vaccination in Adult Allogeneic Stem Cell Transplant Donors and Recipients
2007
Incidence of Invasive Pneumococcal Disease among Individuals with Sickle Cell Disease before and after the Introduction of the Pneumococcal Conjugate Vaccine
2007
Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses
2009 Standout
Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease
1989
Epidemiology of Otitis Media During the First Seven Years of Life in Children in Greater Boston: A Prospective, Cohort Study
1989 Standout
Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials
2001
Immunization of Pediatric Solid Organ Transplant Candidates and Recipients
2000
Staphylococcus aureusInfections
1998 Standout
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older
1999
The plant immune system
2006 StandoutNature
SARS-CoV-2 vaccines in development
2020 StandoutNature
Effect of age, sex and smoking habits on pneumococcal antibodies in an elderly population
1997
Efectividad de la vacuna frente al neumococo en el anciano. Revisión sistemática y metaanálisis
2002
BACTERIAL PNEUMONIA ASSOCIATED WITH HIV-1 INFECTION
1996
Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in children with human immunodeficiency virus undergoing highly active antiretroviral therapy
2004
Antibody Responses in Postsplenectomy Trauma Patients Receiving the 23-Valent Pneumococcal Polysaccharide Vaccine at 14 versus 28 Days Postoperatively
2002
Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation
1995
Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside.
1994
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
The Influence of HIV Infection on Antibody Responses to a Two-Dose Regimen of Influenza Vaccine
1989
Safety and efficacy of hepatitis B vaccine in systemic lupus erythematosus
2007
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.
2001
Protein-Carbohydrate Interaction
1967
Quantification of Coomassie Blue stained proteins in polyacrylamide gels based on analyses of eluted dye
1975
Pneumococcal Vaccine in the Institutionalized Elderly: Design of a Nonrandomized Trial and Preliminary Results
1981
Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1.
1991 StandoutNobel
Pneumococcal vaccination. Controversies and opportunities.
1990
Molecular Biology and Chemistry of the Alternative Pathway of Complement
1980
Specific purification of equine anti-SII antibodies by precipitation with A hemocyanin-glucuronide conjugate
1967
Avidity as a Determinant of the Protective Efficacy of Human Antibodies to Pneumococcal Capsular Polysaccharides
1999
Cost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly People
1997
Density Variant Glycan Microarray for Evaluating Cross-Linking of Mucin-like Glycoconjugates by Lectins
2012 StandoutNobel
Pneumococcal Infections After Human Bone-Marrow Transplantation
1979
Lectins: Cell-Agglutinating and Sugar-Specific Proteins
1972 StandoutScience
Central Role of Complement in Passive Protection by Human IgG1 and IgG2 Anti-pneumococcal Antibodies in Mice
2003
IMPAIRED HUMAN ANTIBODY RESPONSE TO THE THYMUS-INDEPENDENT ANTIGEN, DNP-FICOLL, AFTER SPLENECTOMY
1985
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide ofStreptococcus pneumoniaein the marginal zone of mouse spleen
2003 StandoutNobel
Escherichia coli : Strains That Excrete an Inhibitor of Colicin B
1969 StandoutScienceNobel
Hospital-Based Pneumococcal Immunization
1990
Two-Photon Laser Scanning Fluorescence Microscopy
1990 StandoutScience
The preparation of two insoluble forms of the phytohemagglutinin, concanavalin A, and their interactions with polysaccharides and glycoproteins
1970
Evolution of Virulence in a Plant Host-Pathogen Metapopulation
2003 Science
Bacteriophage Genes and Bacterial Functions
1962 StandoutScienceNobel
PNEUMOCOCCAL VACCINE IN ABORIGINAL CHILDREN—A RANDOMIZED CONTROLLED TRIAL INVOLVING 60 CHILDREN
1986
STUDIES ON HUMAN ANTIBODIES
1969
Protein-Carbohydrate Interaction
1968
The Human Immunodeficiency Virus: Infectivity and Mechanisms of Pathogenesis
1988 StandoutScience
Revaccination of Renal Transplant and Hemodialysis Recipients With Pneumococcal Vaccine
1986
Impaired Antibody Response to Group B Streptococcal Type III Capsular Polysaccharide in C3- and Complement Receptor 2-Deficient Mice
2003
Streptococcus pneumoniae Infections in 47 Hematopoietic Stem Cell Transplantation Recipients
2007
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.
1995
Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants
2000
Purification by Affinity Chromatography of the Molecular Forms of Acetylcholinesterase Present in Fresh Electric-Organ Tissue of Electric Eel
1972 StandoutNobel
The Pneumococcal Vaccine After 15 Years of Use
1994
Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine
2000
Using the shortwave infrared to image middle ear pathologies
2016 StandoutNobel
Inheritance Pattern and Clinical Response to Splenectomy as a Reflection of Erythrocyte Spectrin Deficiency in Hereditary Spherocytosis
1986 StandoutNobel
The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly
1988
Safety and Immunogenicity of the American Academy of Pediatrics–Recommended Sequential Pneumococcal Conjugate and Polysaccharide Vaccine Schedule in Pediatric Solid Organ Transplant Recipients
2005
Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study
2003
Pneumococcal Disease after Pneumococcal Vaccination
1980
Prevention of pneumococcal disease.
1998
Role of CD47 as a Marker of Self on Red Blood Cells
2000 StandoutScience
Immunochemical studies on the combining site of the blood group H-Specific lectin 1 from Ulex europeus seeds
1978
Bacterial Pneumonia in Patients with the Acquired Immunodeficiency Syndrome
1986
Immunochemical studies on blood groups
1970
Pneumococcal Vaccination of Recipients of Bone Marrow Transplants
1983
Purification and characterization of a lectin (plant hemagglutinin) with blood group A specificity from Dolichos biflorus
1970
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients
2003 StandoutNobel
A meta-analysis of randomized controlled trials
2019 Standout
Immunochemical specificity of the combining site of Wistaria floribunda hemagglutinin
1980
Postsplenectomy sepsis 10 years or more after operation.
1985
Clinical effectiveness of pneumococcal vaccine. Meta-analysis.
1999
Comparing the Means of Several Groups
1985
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
1995 Standout
Protein-carbohydrate interaction
1967
The Crisis in Antibiotic Resistance
1992 StandoutScience
The Structure of the Disaccharide Unit of the Renal Glomerular Basement Membrane
1967
Anticapsular antibody requirements for protection against experimental Haemophilus influenzae type b bacteremia after splenectomy
1988
Cell surface antigens of clonal teratocarcinoma cells at various stages of differentiation
1975 StandoutNobel
In vitro complement-dependent binding and in vivo kinetics of pneumococcal polysaccharide TI-2 antigens in the rat spleen marginal zone and follicle
1996
Protective Efficacy of Pneumococcal Polysaccharide Vaccines
1977
Preventing Pneumococcal Bacteremia in Patients at Risk
1995
Pneumococcal Bacteremia in Charleston County, South Carolina
1990
Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma
1986
Clones from the human gene complex coding for salivary proline-rich proteins.
1984 StandoutNobel
Imaging the glycome
2008 StandoutNobel
Biochemistry of C3 and Related Thiolester Proteins in Infection and Inflammation
1987
Improving the Use of Pneumococcal Vaccine Through a Strategy of Hospital‐based Immunization
1985
Pneumococcal Vaccine Efficacy in Selected Populations in the United States
1986
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Partial deficiency of erythrocyte spectrin in hereditary spherocytosis
1985 StandoutNatureNobel
Pulmonary complications of diabetes mellitus. Pneumonia.
1995
Dolichol Monophosphate Glucose: An Intermediate in Glucose Transfer in Liver
1970 StandoutNobel
Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults
2007
Pneumococcal Vaccination
1990
Purification of Acetylcholinesterase by Affinity Chromatography and Determination of Active Site Stoichiometry
1972
Diagnosis of Bacterial Infections of the Lung
1987
Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow transplantation
1996
Revaccination of Children after Completion of Standard Chemotherapy for Acute Leukemia
2007
Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation
2003
Purification and characterization of a blood-group A reactive hemagglutinin from the snail Helix pomatia and a study of its combining site
1969
Antibody to Langerin/CD207 localizes large numbers of CD8α + dendritic cells to the marginal zone of mouse spleen
2009 StandoutNobel
Recurrent Sinopulmonary Infection and Impaired Antibody Response to Bacterial Capsular Polysaccharide Antigen in Children with Selective IgG-Subclass Deficiency
1985
Carbohydrate binding specificity of four N-acetyl-D-galactosamine-"specific" lectins: Helix pomatia A hemagglutinin, soy bean agglutinin, lima bean lectin, and Dolichos biflorus lectin
1977
Structure of Concanavalin A at 4 Å Resolution
1971 StandoutNobel
Unusual Fragments in the Subunit Structure of Concanavalin A
1971 StandoutNobel
A Controlled Evaluation of the Protective Efficacy of Pneumococcal Vaccine for Patients at High Risk of Serious Pneumococcal Infections
1984
Pneumococcal Polysaccharide Vaccine Efficacy
1993
Conformational Changes in Concanavalin A
1971 StandoutNobel
Studies on the Chemical Basis of the Phage Conversion of O-Antigens in the E-Group Salmonellae*
1962
Use and efficacy of pneumococcal vaccine in patients with Hodgkin disease
1979
Pneumococcal Vaccine After 15 Years of Use
1994
Vaccination anti-pneumococcique : place et indications dans la prévention des infections communautaires des voies respiratoires inférieures
2001
Studies on the mucoproteins of human parotid saliva
1965
Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes
1988
PULMONARY COMPLICATIONS OF DIABETES MELLITUS
1995
Prevention ofotitis media in children by pneumococcal vaccination
1985
Works of Gerald Schiffman being referenced
Decline of Vaccine-Induced Antipneumococcal Antibody in Children With Nephrotic Syndrome
1986
The Role of the Capsular Polysaccharide in the Activation of the Alternative Pathway by the Pneumococcus
1976
Response to Pneumococcal Vaccine among Asymptomatic Heterosexual Partners of Persons with AIDS and Intravenous Drug Users Infected with Human Immunodeficiency Virus
1989
Immunogenicity of the 23-valent pneumococcal polysaccharide vaccine in Alaska native chronic alcoholics compared with nonalcoholic native and non-native controls
1993
INCREASED RISK OF PNEUMOCOCCAL INFECTIONS IN CARDIAC TRANSPLANT RECIPIENTS
1990
Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster therapy
1995
POLYSACCHARIDE CONJUGATE VACCINE RESPONSES IN BONE MARROW TRANSPLANT PATIENTS1
1994
Zidovudine Improves Response to Pneumococcal Vaccine among Persons with AIDS and AIDS-Related Complex
1991
Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination
1991
HLA, Gm, and Km Polymorphisms and Immunity to Infectious Diseases in South Amerinds
2015
Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid
1997
Pneumococcal Vaccine In Elderly Patients With Copd
1983
Immunochemical Studies on Blood Groups.1 XXIV. Some Oligosaccharides Isolated from Dialysates After Mild Acid Hydrolysis of Human Blood Group B Substances from Ovarian Cyst Fluid
1960
Immune Response of Elderly Adults to Pneumococcus: Variation by Age, Sex, and Functional Impairment
1987
Pneumococcal vaccination: The response of patients with multiple myeloma
1980
Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for determination of anti-pneumococcal polysaccharide antibodies.
1983
Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia
1984
Persistence of Protective Pneumococcal Antibody following Vaccination in Patients with the Nephrotic Syndrome
1984
Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients
1981
Pneumococcal Antibodies in Patients with Chronic Obstructive Pulmonary Disease and Their Response to Pneumococcal Capsular Polysaccharides: Preliminary Results
1981
Antibody responses in adult volunteers to pneumococcal polysaccharide types 19F and 19A administered singly and in combination
1982
A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques
1980
Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups
1983
Serum antibody and opsonic responses after immunization with pneumococcal vaccine in kidney transplant recipients and controls
1981
Antibody Response to Pneumococcal Vaccine in Patients With Solid Tumors and Lymphomas
1983
Immunoregulatory role of the spleen in antibody responses to pneumococcal polysaccharide antigens
1987
The presence of sialic acid on two related bacterial polysaccharides determines the site of the primary immune response and the effect of complement depletion on the response in mice.
1982
Antibody Response to Capsular Polysaccharide Vaccine of Streptococcus pneumoniae in Patients with Nephrotic Syndrome
1978
Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides
1984
A controlled study of pneumococcal polysaccharide vaccine in systemic lupus erythematosus
1979
Response of Traumatized Splenectomized Patients to Immediate Vaccination with Polyvalent Pneumococcal Vaccine
1983
Effect of anesthesia and splenectomy on antibody response to pneumococcal polysaccharide immunization.
1982
Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3.
1988
The Role of the Capsular Polysaccharide in the Activation of the Alternative Pathway by the Pneumococcus
1976
Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia.
1986
Immunochemical Studies on Blood Groups. XXVI. The Isolation of Oligosaccharides from Human Ovarian Cyst Blood Group A Substance Including two Disaccharides and a Trisaccharide Involved in the Specificity of the Blood Group A Antigenic Determinant
1962
Clinical Studies of Pneumococcal Vaccines in Infants. II. Efficacy and Effect on Nasopharyngeal Carriage
1981
Immunochemical Studies on Blood Groups XXX. Cleavage of A, B, and H Blood-Group Substances by Alkali*
1964
Pneumococcal capsular polysaccharide vaccination in adult chronic hemodialysis patients.
1980
Antibody Response to Pneumococcal Vaccine in Patients with Multiple Myeloma
1981
Subpopulations of antibodies to phosphocholine in human serum.
1984
Impaired Antibody Response to Pneumococcal Vaccine after Treatment for Hodgkin's Disease
1978
Pneumococcal Immunization in Adult Diabetics
1981
Immunochemical Studies on Blood Groups. XXI. Chromatographic Examination of Constituents Split from Blood Group A, B and O(H) Substances and from Type XIV Pneumococcal Polysaccharide by Clostridium tertium Enzymes1
1958
Immunochemical Studies on Blood Groups.1 XXVII. Periodate Oxidation of Blood Group A, B and O(H) Substances
1962
Immunochemical studies on blood groups. 28. Further studies on the oligosaccharide determinats of blood group B and BP1 specificity.
1962
RESPONSE TO PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH UNTREATED HODGKIN'S DISEASE
1980
Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives.
1985
Serum Antibody and Opsonic Responses to Vaccination with Pneumococcal Capsular Polysaccharide in Normal and Splenectomized Children
1980
Pneumococcal Infection and Immunologic Response to Pneumococcal Vaccine in Chronic Obstructive Pulmonary Disease
1987
Pneumococcal Antibody Levels One Decade After Immunization of Healthy Adults**Mufson MA, Krause HE, Schiffman G, Hughey D: Decline in pneumococcal antibody levels one decade after administration of polysaccharide vaccine. Clin Res 34:222A, 1986.
1987
Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.
1985
Efficacy of Pneumococcal Vaccine in High-Risk Patients
1986
Long-Term Persistence of Antibody following Immunization with Pneumococcal Polysaccharide Vaccine
1983
Response to Pneumococcal Vaccine Among Children with Hodgkin's Disease
1981
Clinical Studies of Pneumococcal Vaccines in Infants. I. Reactogenicity and Immunogenicity of Two Polyvalent Polysaccharide Vaccines
1981
Immunochemical Studies on Blood Groups. XXXI. Destruction of Blood Group A Activity by an Enzyme from Clostridium tertium Which Deacetylates N-Acetylgalactosamine in Intact Blood Group Substances*
1964
Failure of Pneumococcal Vaccine in Children with Sickle-Cell Disease
1979
Pneumococcal Vaccine: A Tool for the Evaluation of the B-Cell Function of the Immune System
1983
Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae
1985
Reactivity and Antibody Responses of Volunteers Given Two or Three Doses of Pneumococcal Vaccine
1984
Radioimmunoassay and opsonic antibody responses to pneumococcal capsular polysaccharide vaccine in serum and ascitic fluid of cirrhotic patients
1983
ANTIBODY RESPONSE TO VACCINATION WITH PNEUMOCOCCAL CAPSULAR POLYSACCHARIDES IN SPLENECTOMIZED CHILDREN
1982
Graphical method for evaluating antibody response to vaccines
1980
Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides
1987
Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure.
1984
Correlation between Serum IgG-2 Concentrations and the Antibody Response to Bacterial Polysaccharide Antigens
1980
CAPSULATION OF PNEUMOCOCCUS WITH SOLUBLE CELL WALL-LIKE POLYSACCHARIDE
1971
Assessment of the Antibody Response to Pneumococcal Vaccine in High-Risk Populations
1981
Inhibition of suppressor-cell activity by cyclophosphamide in patients with malignant melanoma.
1987
Response to pneumococcal vaccine in renal transplant and hemodialysis patients.
1981
Immunization of Immunosuppressed Patients with Pneumococcal Polysaccharide Vaccine
1981
Serum Antibody Responses of High-Risk Children and Adults to Vaccination with Capsular Polysaccharides of Streptococcus pneumoniae
1981
Immunodeterminant specificity of human immunity to type III group B streptococcus.
1979
Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates
1986
The Antibody Responses to Pneumococcal Capsular Polysaccharides in Aged Individuals
1980
Response of Patients with Hodgkin's Disease to Pneumococcal Vaccine
1979
Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus.
1984
A new 23 valent pneumococcal vaccine: Immunogenicity and reactogenicity in adults
1985
Immunochemical Studies on Blood Groups. XXXII. Immunochemical Properties of and Possible Partial Structures for the Blood Group A, B, and H Antigenic Determinants*
1964
IMMUNE RESPONSE AFTER SPLENECTOMY
1978
7. Prevention of Pneumococcal Pneumonia by Vaccination
1985
Impaired response to pneumococcal vaccine in systemic lupus erythematosus
1980